Beyond small molecules: Biotech Drugs

The development of novel bio(techno)logical drugs, mainly consisting in antibodies, can significantly exploit molecular modeling tools to successfully accelerate discovery. In my presentation, I will introduce participants to the most up-to-date antibody modeling techniques  with specific applications aimed at predicting their interaction with antigens, and mutagenesis for their optimization.